Biocept
is a California-based molecular diagnostics company that researches and develops molecular diagnostic assays for the treatment of cancer... Read moreBiocept
is a California-based molecular diagnostics company that researches and develops molecular diagnostic assays for the treatment of cancer... Read more
News
Feb 04, 2025
Openpr
Biocept: Liquid Biopsy Market In-depth Insights, Business Opportunities and top companies Analysis forecast by 2032 | Biocept, Inc., Qiagen N.V., Trovagene
Jan 31, 2025
Thebusinessgazetteonline
Biocept: Liquid Biopsy Tube Market to Gain Momentum with 20.24%CAGR, Reaching 45.0 Billion USD by 2032 | Hologic, Biocept
Dec 11, 2024
Einnews
Biocept: Genomic Cancer Testing Market CAGR of 16.7% Share, Opportunities and Growth Forecast 2024-2031 | Illumina, Inc., Biocept
May 17, 2024
Rewind1019
Biocept: Liquid Biopsy Market Worldwide Industry Analysis, Future Demand, And Forecast Till 2031 | Biocept, Inc., Qiagen N.V.
Apr 10, 2024
Middleeastnewswatch
Biocept: Genomic Cancer Testing Market 2024, Business Growing Strategies, Regional Growth by 2031: Biocept, Inc, Tempus Labs, Inc
Oct 16, 2023
Benzinga
Biocept: Why Is Liquid Biopsy Firm Biocept Stock Trading Lower Today?
Oct 16, 2023
MarketScreener
Biocept: Biocept : Bankruptcy - Form 8-K
Sep 24, 2023
Trendradars
Biocept: Biocept to Present at the LD Micro Main Event XV
Sep 22, 2023
Marketscreener
Biocept: Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept's CNSide Assay to Evaluate Patients with Leptomeningeal Metastases
Sep 11, 2023
Pharmabiz
Biocept: Plus Therapeutics expands supply agreement with Biocept for cerebrospinal fluid tumour cell enumeration assay
Biocept Competitors
1
2
3
4
5
6
7
8
9
10